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Abstract
In this paper, an analogue of hirsutine (compound 1) has been synthesized and evaluated as
an anti-hypertension agent, which exhibits extraordinary effects on the contractile response
of thoracic aorta rings frommale SD rats in vitro (IC50 = 1.129×10
-9±0.5025) and the abilities
of reducing the systolic blood pressure (SBP) and heart rate (HR) of SHR in vivo. The mecha-
nism investigation reveals that the vasodilatation induced by compound 1 is mediated by
both endothelium-dependent and -independent manners. The relaxation in endothelium-in-
tact aortic rings induced by compound 1 can be inhibited by L-NAME (1×10-6 molL-1) and
ODQ (1×10-6 molL-1). Moreover, compound 1 can also block Ca2+ influx through L-type Ca2+
channels and inhibit intracellular Ca2+ release while no effect on K+ channel has been ob-
served. All these data demonstrated that the NO/cyclic GMP pathway can be involved in en-
dothelium-dependent manner induced by compound 1. Meanwhile the mechanism on the
vasodilatation of compound 1 probably also related to blockade of Ca2+ influx through L-type
Ca2+ channels and inhibition of intracellular Ca2+ release may have no relationship with
K+ channels.
Introduction
Hypertension has been considered as a common risk factor for progression of cardiovascular
disorders and often accompanied by endothelium dysfunction, metabolic syndrome, diabetes,
renal dysfunction, increased peripheral vascular resistance, and excessive activation of the
renin-angiotensin system[1]. Each type of anti-hypertension medicine has its advantages and
disadvantages, and that most patients with hypertension required life-long medication, the dis-
covery of new agents with higher efficacy and lower toxicity has become one of the prime tasks
for medicinal chemists and biologists[2].
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Uncaria rhynchophylla, a traditional Chinese herb medicine, has been proven that it has a
significant effect of anti-hypertension. Several integrant of Uncaria rhynchophylla has been iso-
lated, such as rhynchophylla, hirsutine, corynantheine, isocorynoxeine, and all of them have
been identified as indole alkaloids[3]. Recently, we reported that hirsutine, an integrant of
Uncaria Rhynchophylla, has cardioprotection on hypoxic neonatal rat cardiomyocytes[4]. In
order to acquire a deeper understanding and more detailed knowledge on the pharmacological
functions and clinical applications of the indole alkaloids from Uncaria rhynchophylla, hirsu-
tine and its analogues have been synthesized, and we find that compound 1, one of analogues
of hirsutine, exhibits remarkable antihypertensive and dilating effect both in vitro and in vivo.
In the further studies, we also reveal that its dilation mechanisms are involved in both endothe-
lium-dependent and—independent pathways, especially for the pathways modulated by NO
and Ca2+ related proteins. In additionally, we observed that neither the non-specific ATP-sen-
sitive K+ channel nor the Ca2+-activated K+ channel might have relationship with the vasodila-
tion effect induced by compound 1. With these results we has originally show the anti-
hypertension effect and vasodilation mechanisms of compound 1 which are very important for
it as a new anti-hypertension drug candidate.
Materials and Methods
Chemicals and drugs
Compounds 1 was prepared as outlined in Scheme 1. First of all, compound 2 was synthesized
according to the method provided by literature[5]. And then, the condensation between com-
pound 2 and (R)-2-((tert-butoxycarbonyl)amino)-3-(prop-2-yn-1-ylthio) propanoic acid was
performed in the presence of DIC and DPTS to give compound 3 in 81% yield. Finally, the Boc
group in compound 3 was removed under acidic condition, affording target compound 1 in
59% yield (Fig 1).
NG-Nitro-L-arginine Methyl Ester (L-NAME), glibenclamide, indomethacin, nifedipine,
TEA, captopril, atropine and ODQ were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). Phenylephrine (PE) and norepinephrineHCl (NE) were obtain from Shanghai Hefeng
Pharmaceutical Co.(China). All other reagents were analytical grade.
Fig 1. The synthetic route of compound 1.
doi:10.1371/journal.pone.0119477.g001
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Compound 1 could be dissolved by distilled water and anhydrous ethanol and another re-
agents were stored as aqueous solution except glibenclamide and nifedipine, which must be
dissolved in DMSO. The pre-study revealed that the dosage of DMSO and anhydrous ethanol
had no influence on increasing isolated aorta tension or reducing blood pressure. All reagents
should be pre-sterilizated during next experiments.
Toxicity test by MTT and LDH Elisa kit
Firstly, cultured rat aortic smooth muscle cells as previously described[6]. Briefly, male SD rat
(150–200 g) was anaesthetized using chloral hydrate (2mg/100g). The main aortic artery was
dissected out and kept in ice-cold PBS with pH adjusted to 7.4 with NaOH. The artery was cut
into 1mm2 pieces, and incubated in Collagenase II containing Penicillin and streptomycin at
37°C for 3 hours, then centrifuged the solution and removed the supernatant. Finally, place the
single piece respectively on the petri dish and put into a little DMEM containing 20% supple-
mented fetal bovine serum (FBS) for a few days to let the VSMCs climb out from the issue.
The VSMCs were cultured in DMEM containing 10% FBS, 100 U/mL penicillin, and
100mg/mL streptomycin. The VSMCs were identified by SMC-specific α-actin monoclonal an-
tibody (Sigma, Oakville, Ontario, Canada) which showed the obvious brown grain and the typ-
ical ‘hill-and-valley’ pattern[7]. Once the cells got 70–80% confluence, the experiments could
be implemented, between passages 3 and 10.
Cell toxicity test was accessed by MTT (Sigma, St. Louis. MO, USA).Briefly, cells were plated
on 96-well plates (approximately 6000 cells/well) in culture medium and maintained in regular
growth medium for 2 days. Cells were pretreated for 12 h with compound 1 (1.6, 8,
40,200,1000μΜ), removed the medium and washed twice with phosphate-buffered saline
(PBS). Incubated with MTT (500ug/mL) for 4h and add dimethylsulfoxide (150μl/well). After
10 min at room temperature, the absorbance was read at 490 nm, with 690 nm as reference.
Cell viability (%) was calculated as the absorbance of each group divided by the absorbance of
the normal control multiplied by 100[4].
Additional assessment of cell viability was conducted by measurement of LDH leakage from
cells into the medium[8]. LDH (lactate dehydrogenase) released into the culture medium was
determined using an LDH Assay Kit (Biotime, Haimen, China). Results were analyzed spectro-
photometrically at 490 nm. Relative LDH release is expressed as a percentage of that of normal
cells. Control (100%) was defined as LDH leakage into the medium from cells in normal
samples.
Effect of compound 1 in vasodilation and anti-hypertension
Vasodilation Activity. To determine the vasodilation activity of compound 1, Sprague-
Dawley rats (200–250g) were sacrificed after anesthesia with chloral hydrate (20mg/kg) and
immerse the thoracic aortas in Physiological Salt Solution (PSS) which contains (mM): NaCl,
120.6; KCl, 5.9; CaCl2, 2.5; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 15.4; glucose, 11.5, pH 7.4.
Each aortas must be removed from tissue and fat, then have it cut into 3–4 rings (3–5 mm). A
stainless steel triangular hook get each ring through and put them into a bath filled with 10ml
PSS at 37°C with mixed gas of 95% O2 and 5% CO2. Then connect the rings with the tension
transducer (Shanghai Jialong Instrument Factory, China) which has already connected to
SUMP-PC biological signal processor (Shanghai Jialong Instrument Factory, China) so as to
measure isometric tension in the vessels, under an optimal tension of 2g. The bath fluid was
changed every 15 min.
The aortic rings with endothelium were pre-contracted with PE (10–6 molL-1). Adding cu-
mulative compound 1 with the concentration gradually increasing from 10–11 to 10–4 molL-1
A Novel Compound for Anti-Hypertension Research
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when the maximum tension was achieved to obtain the concentration–response curve of com-
pound 1-induced relaxation. Endothelial integrity was identified by the level of relaxation
caused by acetylcholine (10–5 molL-1) under the isometric tension induced by phenylephrine
(10–6 molL-1). As previous study showed, the evaluation standard for endothelium-intact ves-
sels is that the acetylcholine-induced relaxation achieves 80% or greater[9] and the same vol-
ume solvent alcohol was added as control group.
We also make natural hirsutine as a control to assess the relative potency of vasodilator ef-
fect of the analogue of hirsutine. The rings were pre-contracted with PE (10–6 molL-1), and
then add to cumulative compound 1 or natural hirsutine with the concentration gradually in-
creasing from 10–11 to 10–4 molL-1. Obtain the concentration-response curve and make com-
parison between these two groups.
Experimental Animals. There were seven groups in this experiment and each group has
included at least six rats. Male Spontaneously Hypertensive Rats during 250–350 g were used.
All animal care and experimental protocols complied with the Animal Management Rules of
the Ministry of Health of the People’s Republic of China and approved by the local ethical com-
mittee of Fudan University. All surgery was performed under anesthesia of chloral hydrate or
pentobarbital sodium, and all efforts were made to ameliorate animal suffering.
Induction of Intubation Technology. We use the Left Carotid Artery Intubation Tech-
nology to evaluating anti-hypertensive activity of compound 1. Briefly, after anesthesia with
chloral hydrate (20mgkg-1), make the rat on supine position and implement endotracheal in-
tubation. Separate the left carotid artery from the valgus and insert a polyethylene plastic pipe,
which is filled with 0.1% heparin saline, into the artery pointing to the centripetal end. Then
get the other end of the pipe throughout rat’s head back. Finally, suture the neck and head back
incision and wait for the next day to let the rat awake. The rats should be maintained free for
food or water during the next 12 hours before monitoring—blood pressure.
Drug Administration and blood pressure monitoring. On the next day, each rat was
placed in a normal cage and we use the pipe out of their head back to connect with the blood
pressure transducer via a tee interface, and transfer the digital information into computer by
SMUP-PC biological signal processing system (Shanghai Jialong Instrument Factory, China).
Compound 1 at the dose of 5, 10 and 20 (mgkg-1) were respectively administered by tail vein
injection in awake rats after record the basal blood pressure. Then do the same thing on the
group of SHR. Then continuously observe and record the change of blood pressure and heart
rate in 1 hour.
Compound 1-induced endothelium-dependent and-independent relaxations. The en-
dothelium-intact and endothelium-denuded aortic ring were pre-contracted with PE (10−6 molL-1).
Once get to the maximum isometric tension, continuous concentration–response curve of com-
pound 1 (10–11 molL-1) were obtained. Make comparison between in absence and presence of
endothelium groups.
Role of nitric oxide (NO) and guanylyl cyclase in compound 1-induced relaxation. En-
dothelium-intact aortic rings were pre-incubated for 15 min, respectively with L-NAME, a NO
synthase inhibitor (10–4 molL-1)[10,11] and ODQ, a specific inhibitor of soluble guanylyl cyclase
(10–6 molL-1)[12]. After that, aortic rings prior to contraction with PE (10−6 molL-1) to get to the
plateau, then continuously add cumulative concentrations of compound 1 (10-11-10-4 molL-1) to
the bath so as to obtain the concentration–response curve of compound 1-induced relaxation.
Compared with the control group to determine the response effect.
Role of muscarinic acetylcholine in compound 1-induced relaxation. To determine if
muscarinic acetylcholine receptor play a role in compound 1-induced vasodilation, add atro-
pine (a acetylcholine receptor inhibition) at the dose of 10–4 molL-1 to the bath for 15 min be-
fore contracting the endothelium-intact rings with PE (10−6 molL-1), then use increasing
A Novel Compound for Anti-Hypertension Research
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concentrations of compound 1 (10-11-10-4 molL-1) to get the curve. Access the effect by com-
paring with the control group.
Effect of compound 1 on extracellular Ca2+-induced contraction activated by KCl. Cal-
cium is an essential signaling molecule that controls vascular smooth muscle cells (VSMCs)
contraction and nifedipine is a common calcium antagonist[13]. Aortic rings without endothe-
lium were contracted by KCl (80 mM) to reveal whether the inhibition of extracellular Ca2+ in-
flux had something with the compound 1-induced relaxation. Then concentration–dependent
curve of compound 1 was obtain by adding the cumulative compound (10-11-10-4 molL-1),
then use nifedipine instead of compound 1 so as to get another curve. Finally, the compound 1
group was compared respectively with nifedipine group.
Role of the PE-induced sarcoplasmic reticulum calcium release. To clarify if the inhibi-
tion of intracellular Ca2+-release caused the compound 1-induced vasodilation effect, firstly
stimulate the release of sarcoplasmic reticulum calcium completely by contracting the rings in
PSS with Ca2+ by PE as previously said until obtain the plateau. Then endothelium-denuded
rings were washed by Ca2+-free PSS for three times and add compound 1 at different concen-
trations as follows (molL-1):10–9,10–8,10–7,10–6,10–5 and 10–4 which to be dependent groups.
The compound was present during 15 min and at last, PE (10−6 molL-1) was added again to
help the intracellular Ca2+ release. The maximal isometric tension induced by PE firstly (com-
pound-free) was considered as 100%.
Role of potassium channels in compound 1-induced relaxation. In order to know the
role of K+ channels on compound 1-induced relaxation, arterial rings whose endothelium-de-
nuded incubated in advance using the K+ channel blockers, TEA (5×10−6 molL-1), glibencla-
mide (10−5 molL-1) for 15 min before stimulated by PE (10−6 molL-1), and then the
compound was added into the bath continuously from 10–11 to 10–4 molL-1.
Data analysis
Firstly, we calculated the contraction value of each compound at each time point by EXCEL,
using the following formula:
Contraction valueðyaxisÞ ¼ each compound tensionbaseline tension
Maximum tensionbaseline tension
And then do the analysis of IC 50 with one-way ANOVA as well as Turkey's multiple com-
parison test. The data of curves would be modified by a nonlinear regression method (Graph-
Pad Prism). Results were presented as means±standard error of the mean (S.E.M.). What’s
more, we do analysis of P value with two-way ANOVA from GraphPad Prism. The data of the
two groups would be compared with a repeated measures ANAVOmethod.
Results
Toxicity test by MTT and LDH Elisa kit
Compound 1 had no toxicity on cell viability during the normal dosage range, as accessed by
MTT assay, compared with the normal control group. When VSMCs were treated with com-
pound 1 (1.6,8,40,200,1000μΜ) for 12h, only the 1mM group had toxicity on the cells respec-
tively compared with the control group (Fig 2A).
Lactate dehydrogenase leakage (LDH) evaluated also has no more higher than in the control
group during the normal dosage range and compound 1 had indeed no effect on cell death,
which was consistent with the result observed with the MTT assay (Fig 2B).
A Novel Compound for Anti-Hypertension Research
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Effect of vasodilation and anti-hypertension
Compound 1 could diastole aortic rings with endothelium after stimulated by PE (10−6 molL-1)
in a dose-dependent manner as well as the IC50 (Concentration necessary to reduce maximal
phenylephrine induced contraction by 50%) was 1.129×10–9±0.5025 (Fig 3A).
In vivo study, systolic blood pressure (SBP) and heart rate (HR) were recorded for 1h and
baseline parameter before injecting compound 1 (5,10,20 mgkg-1) were considered with 100%
of activity. There is a significant reduction in SBP and HR during the first 0.5h after adminis-
trating 20mg/kg compound 1 and the anti-hypertensive effect of compound 1 was slowly and
continuously get to the basal line (Fig 3B and 3C).
In further study, we found that the vasodilation effect of compound 1 could not be signifi-
cant differences than that of natural hirsutine, only at the concentration of 10-8M could show
Fig 2. Toxicity test by MTT and LDH Elisa kit. A. The MTT assay. The toxicity was accessed by measuring
cell death using the MTT assay. B. LDH release assay. For each group was standardized with the respective
control and results were as the mean ± S.E.M., n = 6, ***P<0.001, compared with the DMSO group.
doi:10.1371/journal.pone.0119477.g002
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the obvious differences (P<0.05). That is to say, our novel compound has the similar great va-
sodilation effect compared with the natural one. Meanwhile, it is easier to synthesize com-
pound 1 (Fig 3D).
Compound 1-induced endothelium-dependent and-independent
relaxations
The vasodilation effect induced by compound 1, with PE (10−6 molL-1) pre-contracted, was
significantly impaired when endothelium cells were removed physically according to the com-
parison between E+ and E- groups (Fig 4A) which showed that the vasodilation was in partially
endothelium-dependent way.
Fig 3. Effect of vasodilation and anti-hypertension. A. Cumulative concentration of compound 1-induced relaxation precontracted with 1 μMPE in rat
aortic rings with functionally intact endothelium. Means ± S.E.M, n = 6 rings,***P<0.001vs Ethanol control group. B. The reduction rate of systolic blood
pressure (SBP). C. The reduction rate of heart rate. Results are presented as mean ± S.E.M., n = 6, *P<0.05, **p<0.01vs SHR group. D. The different effect
between compound 1 and natural hirsutine relaxation. Results are presented as mean ± S.E.M., n = 6, *P<0.05 compared with compound 1 group.
doi:10.1371/journal.pone.0119477.g003
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Fig 4. Compound 1-induced endothelium-dependent and-independent relaxations. a. The differences
between compound 1-induced endothelium-dependent and—independent relaxation. b. Effects of L-NAME
(1uM) on compound 1-induced relaxation in endothelium-denuded aortic rings. c. Effects of ODQ (1uM) on
compound 1-induced relaxation in endothelium-denuded aortic rings. Results are presented asmean ± S.E.M.,
n = 6, *P<0.05,**p<0.01,***P<0.001 compared with compound-only group.
doi:10.1371/journal.pone.0119477.g004
A Novel Compound for Anti-Hypertension Research
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Role of nitric oxide and guanylyl cyclase in compound 1-induced
relaxation
For further study the eNO synthase had been confirmed to be involved in this vasodilation pro-
cess (Fig 4B). What’s more, the use of ODQ can almost completely inhibit the compound 1-in-
duced relaxation (Fig 4C). So NO and sGC would have important effect on the issue how
compound 1 played diastole role through endothelium-dependent manner.
Role of muscarinic acetylcholine in compound 1-induced relaxation
Through this experiment the M-R function in compound 1-induced relaxation can be excluded
because only at the concentration of 10–5 molL-1 compound 1 did the Atropine at presence or
absence groups have significant differences (Fig 5), and this result had no concentration-re-
sponse trend.
Effect of compound 1 on extracellular Ca2+-induced contraction
activated by KCl
When respectively compared the compound 1 group with the nifedipine group, we can find
that there is no distinctly differences between the two groups but the relaxation trend of com-
pound 1 is as same as nifedipine (Fig 6A), which indicated that compound 1 relaxed vessels
partially through inhibiting extracellular Ca2+ influx.
Role of the PE-induced sarcoplasmic reticulum calcium release
In the Ca2+-free PSS, incubated with compound 1 (10–9,10–8,10–7,10–6,10–5 and 10–4 molL-1)
for 15 min after completely release the intracellular Ca2+ and from the concentration of 10–7
molL-1 that compound 1 could evidently attenuate PE (10−6 molL-1) induced contraction
(Fig 6B), showed that the compound also cause an inhibition on the sarcoplasmic reticulum
calcium release.
Fig 5. Role of Atropine (1 × 10–6 molL-1) in the vasodilation induced by compound 1. Use the
endothelium-denuded aortic rings. Data are showed as mean ± S.E.M., n = 6, *P<0.05
doi:10.1371/journal.pone.0119477.g005
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Role of potassium channel in compound 1-induced relaxation
Both of the K+ channel blockers, glibenclamide (10−5 molL-1) or TEA (5x10−6 molL-1), had
no obviously effect on inhibiting compound 1-induced relaxation in endothelium-denuded
rings pre-stimulated by PE (10–6 molL-1) (Fig 7A and 7B).
Discussion
Previous studies show that hirsutine can relax the aortic vessels against phenylephrine-induced
contraction in a concentration-dependent way[3]. To develop more potent compounds, an an-
alogue of hirsutine, compound 1 was designed basing on the structure of hirsutine. The phar-
macological studies of compound 1 show that it can vasodilator thoracic aorta at a very low
concentration (IC50 is 10
–9 molL-1), and the animal studies exhibit that compound 1 can
Fig 6. Role of calcium channel in compound 1-induced relaxation. A. Comparison of compound 1 and
nifedipine on KCl-activated (80mM) contraction in the endothelium-denuded rings. B. Role of the PE-induced
sarcoplasmic reticulum calcium release. Data are showed as mean ± S.E.M., n = 6, *P<0.05,** P<0.01,
*** P<0.001.
doi:10.1371/journal.pone.0119477.g006
A Novel Compound for Anti-Hypertension Research
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evoke a quick and significant effect on reducing basal SBP and HR (P<0.05) by intravenously
administration of compound 1 in SHR, which is consistent with the vasodilation results and
further demonstrated the anti-hypertensive effect of this compound.
Differing from nifedipine that could induce blood pressure reduction accompanied with a
sustained elevation of the HR[14], compound 1 can decreases both BP and HR what would be
safer for the therapy of cardiovascular diseases. Meanwhile, we find that compound 1 exhibits
extremely low toxicity under effective dose, which indicates that compound 1 will be an ideal
and safe medicine candidate.
As far as we are concerned, the putative mechanisms eventually involved in the blood pres-
sure changes and in vasodilation of hirsutine have been studied in many other researches be-
fore. In general, taking the mechanisms involved in hirsutine’s anti-hypertension effect into
consideration[15], we assumed that both endothelium dependent and independent ways play a
Fig 7. Role of potassium channel in compound 1-induced relaxation. A. Role of glibenclamide
(10−5molL-1) on no-endothelium aortic rings pre-stimulated by PE(10–6 molL-1) in the vasodilation
induced by compound 1. B. Effect of TEA (5x10−6molL-1) on compound 1 vasodilation. Data are
showed as mean ± S.E.M., n = 6.
doi:10.1371/journal.pone.0119477.g007
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role on compound 1’s vasodilatation effects. So we designed those experiments related to NO/
cGMP pathway, muscarinic acetylcholine function, Ca2+ channel as well as K+ channel and
identify whether they can have effects on the vasodilation of compound 1.
From the results that compound 1 impacted PE-induced contraction on endothelium-intact
and-denuded aortic rings, we can see significant differences which indicate endothelial integri-
ty involved in the vasorelaxation caused by compound 1. Furthermore, we find that L-NAME,
an inhibitor of eNOS, can also block the effect of compound 1. As the cardiovascular effect of
nitric oxide is mainly mediated by activation of soluble guanylate cyclase (sGC), in next step
the aorta from SD rats was pre-treated by ODQ, an inhibitor of sGC, and we observed that it
could distinctly weaken the response triggered by compound 1 in endothelium-intact vessels,
suggesting that cyclic nucleotide-cGMP might be involved in the compound 1-mediated vaso-
dilation. Therefore, these data demonstrated that compound 1 dilates vessels in endothelium-
dependent manner which particularly related to NO release from endothelial resulted from
cGMP activation, then bring about vasodilatation, that is to say, the NO/cyclic GMP pathway
is involved in the relaxation progress.
And we can obtain the conclusion from the next experiment that the muscarinic acetylcho-
line effect in compound 1-induced relaxation mechanism can be excluded since Atropine at
presence or absence groups have no significant differences and we cannot see the concentra-
tion-response trend.
Then as we all know, high K+-induced (80mM) contraction in endothelium-denuded aortic
rings is due to cell membrane depolarization and activation of the voltage-dependent Ca2+
channel, especially for L-type Ca2+ channel which could promote Ca2+ influx[16,17]. Accord-
ing to our present study, both compound 1 and nifedipine can inhibit high K+-induced con-
traction in a concentration-dependent manner. On the other hand, compound 1 also has
significant effect on phenylephrine-induced contraction in a dose-dependent manner, which
mostly related to receptor-operated Ca2+ channel. The inositol trisphosphate (IP3) can activates
the IP3 receptor (IP3R) to release stored calcium (Ca
2+) from sarcoplasmic reticulum[18]. All
of these results preliminarily reveal that the mechanism of compound 1-induced dilation in
vascular smooth muscle tissues includes both inhibiting extracellular Ca2+ entry by L-type Ca2+
channel in depolarized tissues and blocking the intracellular Ca2+ release from sarcoplasmic re-
ticulum through a possible IP3 signaling pathway[19]. Another important ion channel, K
+
channel also has close ties to vessel relaxation. There are two main K+ channels we studied in
this content: the non-specific ATP-sensitive K+ channel and the Ca2+-activated K+ channel
[20]. Pre-treatment with glibenclamide or TEA cannot change the concentration-dependent
curve relaxed by compound 1. So neither of these two K+ channels has significant effect on
compound 1-induced dilation which suggests that opening K+ channels is not involved in the
mechanism of action of compound 1.
Further, some possible confounding factors and possible study limitations, such as evaluat-
ing 24-hour urinary sodium and potassium excretion, were not related to some related mecha-
nisms of action. Firstly, we can see that the potassium channel has no effect on compound 1’s
vasodilation and then those tests related to potassium channel are not very necessary to do.
What’s more, we have no enough idea about compound 1 so far and just want to get initial un-
derstanding of it. As we know, the icon channels may play the roles because of activating some
proteases, the progress of which is transient and in a short time so that we cannot get the signif-
icant differences through those long-term study. Considering all of these factors, we didn’t de-
sign the long-term experiments in our current study.
In conclusion, our results suggests that compound 1 can induce vasodilation in rat aortic
rings and reduction in SBP and HR which mediated by both endothelium-dependent and-in-
dependent manners, and NO/cyclic GMP pathway can be involved in endothelium-dependent
A Novel Compound for Anti-Hypertension Research
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manner. Meanwhile the mechanism on compound 1-induced vasodilatation probably also re-
lated to blockade of Ca2+ influx through L-type Ca2+ channels and inhibition of intracellular
Ca2+ release.
Author Contributions
Conceived and designed the experiments: YZZ KZ XFG. Performed the experiments: KZ SNY
FFM. Analyzed the data: KZ SNY. Contributed reagents/materials/analysis tools: YZZ YCZ
XFG. Wrote the paper: KZ XFG.
References
1. Vergara-Galicia J, Ortiz-Andrade R, Castillo-España P, Ibarra-Barajas M, Gallardo-Ortiz I, et al. (2008)
Antihypertensive and vasorelaxant activities of Laelia autumnalis are mainly through calcium channel
blockade. Vascular pharmacology 49: 26–31. doi: 10.1016/j.vph.2008.04.002 PMID: 18534917
2. Egan BM (2013) Prediction of incident hypertension. Health implications of data mining in the ‘Big Data’
era. Journal of Hypertension 31: 2123–2124. doi: 10.1097/HJH.0b013e328365b932 PMID: 24096252
3. Ndagijimana A, Wang X, Pan G, Zhang F, Feng H, et al. (2013) A review on indole alkaloids isolated
from Uncaria rhynchophylla and their pharmacological studies. Fitoterapia 86: 35–47. doi: 10.1016/j.
fitote.2013.01.018 PMID: 23376412
4. Wu LX, Gu XF, Zhu YC, Zhu YZ (2011) Protective effects of novel single compound, Hirsutine on hyp-
oxic neonatal rat cardiomyocytes. European journal of pharmacology 650: 290–297. doi: 10.1016/j.
ejphar.2010.09.057 PMID: 20940014
5. Tietze LF, Zhou Y (1999) Highly Efficient, Enantioselective Total Synthesis of the Active Anti‐Influenza
A Virus Indole Alkaloid Hirsutine and Related Compounds by Domino Reactions. Angewandte Chemie
International Edition 38: 2045–2047.
6. Lu Y, Hanna ST, Tang G, Wang R (2002) Contributions of Kv1. 2, Kv1. 5 and Kv2. 1 subunits to the na-
tive delayed rectifier K+ current in rat mesenteric artery smooth muscle cells. Life sciences 71: 1465–
1473. PMID: 12127166
7. Yang G, Wu L, Bryan S, Khaper N, Mani S, et al. (2010) Cystathionine gamma-lyase deficiency and
overproliferation of smooth muscle cells. Cardiovascular research 86: 487–495. doi: 10.1093/cvr/
cvp420 PMID: 20051385
8. Xin H, Liu XH, Zhu YZ (2009) Herba leonurine attenuates doxorubicin-induced apoptosis in H9c2 cardi-
ac muscle cells. European journal of pharmacology 612: 75–79. doi: 10.1016/j.ejphar.2009.03.067
PMID: 19356731
9. Cacanyiova S, Dovinova I, Kristek F (2013) THE ROLE OFOXIDATIVE STRESS IN ACETYLCHO-
LINE-INDUCED RELAXATIONOF ENDOTHELIUM-DENUDED ARTERIES. Journal of Physiology
and Pharmacology 64: 241–247. PMID: 23756399
10. Pinto NV, Assreuy AMS, Coelho-de-Souza AN, Ceccatto VM, Magalhães PJC, et al. (2009) Endotheli-
um-dependent vasorelaxant effects of the essential oil from aerial parts of Alpinia zerumbet and its
main constituent 1, 8-cineole in rats. Phytomedicine 16: 1151–1155. doi: 10.1016/j.phymed.2009.04.
007 PMID: 19524416
11. Magalhães PJC, Lahlou S, Jucá DM, Coelho-de-Souza LN, Frota D, et al. (2008) Vasorelaxation in-
duced by the essential oil of Croton nepetaefolius and its constituents in rat aorta are partially mediated
by the endothelium. Fundamental & clinical pharmacology 22: 169–177.
12. Yeh J-L, Liou S-F, Liang J-C, Lee C-H, Chiu C-C, et al. (2005) Labedipinedilol-C: a third-generation
dihydropyridine-type calcium channel antagonist displaying K+ channel opening, NO-dependent and
adrenergic antagonist activities. Journal of cardiovascular pharmacology 46: 130–140. PMID:
16044023
13. Kaimoto T, Yasuda O, Ohishi M, Mogi M, Takemura Y, et al. (2010) Nifedipine inhibits vascular smooth
muscle cell dedifferentiation via downregulation of Akt signaling. Hypertension 56: 247–252. doi: 10.
1161/HYPERTENSIONAHA.110.149781 PMID: 20530298
14. Ziegelhoffer A, Mujkosova J, Ferko M, Vrbjar N, Ravingerova T, et al. (2012) Dual influence of sponta-
neous hypertension on membrane properties and ATP production in heart and kidney mitochondria in
rat: effect of captopril and nifedipine, adaptation and dysadaptation. Canadian Journal of Physiology
and Pharmacology 90: 1311–1323. doi: 10.1139/y2012-107 PMID: 22913569
15. Ndagijimana A, Wang XM, Pan GX, Zhang F, Feng H, et al. (2013) A review on indole alkaloids isolated
from Uncaria rhynchophylla and their pharmacological studies. Fitoterapia 86: 35–47. doi: 10.1016/j.
fitote.2013.01.018 PMID: 23376412
A Novel Compound for Anti-Hypertension Research
PLOS ONE | DOI:10.1371/journal.pone.0119477 April 24, 2015 13 / 14
16. Pereira SL, Kummerle AE, Fraga CAM, Barreiro EJ, Sudo RT, et al. (2014) Vasodilator and antihyper-
tensive effects of a novel N‐acylhydrazone derivative mediated by the inhibition of L‐type Ca2+ chan-
nels. Fundamental & clinical pharmacology 28: 29–41.
17. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K-I, et al. (1997) Calciummovements, distribution,
and functions in smooth muscle. Pharmacological reviews 49: 157–230. PMID: 9228665
18. Venturi E, Sitsapesan R, Yamazaki D, Takeshima H (2013) TRIC channels supporting efficient Ca2+
release from intracellular stores. Pflügers Archiv-European Journal of Physiology 465: 187–195.
19. Zhu X-M, Fang L-H, Li Y-J, Du G-H (2007) Endothelium-dependent and-independent relaxation in-
duced by pinocembrin in rat aortic rings. Vascular pharmacology 46: 160–165. PMID: 17074538
20. Li P-Y, Zeng X-R, Cheng J, Wen J, Inoue I, et al. (2013) Rhynchophylline-induced vasodilation in
humanmesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth mus-
cle cells. Naunyn-Schmiedeberg's archives of pharmacology 386: 973–982. doi: 10.1007/s00210-013-
0888-6 PMID: 23812676
A Novel Compound for Anti-Hypertension Research
PLOS ONE | DOI:10.1371/journal.pone.0119477 April 24, 2015 14 / 14
